7-150289479-G-C
Variant summary
Our verdict is Uncertain significance. Variant got 1 ACMG points: 2P and 1B. PM2BP4
The NM_001164458.2(ACTR3C):āc.268C>Gā(p.Gln90Glu) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.0000176 in 1,588,270 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Consequence
NM_001164458.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 1 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ACTR3C | NM_001164458.2 | c.268C>G | p.Gln90Glu | missense_variant | 4/8 | ENST00000683684.1 | NP_001157930.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ACTR3C | ENST00000683684.1 | c.268C>G | p.Gln90Glu | missense_variant | 4/8 | NM_001164458.2 | ENSP00000507618.1 |
Frequencies
GnomAD3 genomes AF: 0.00000663 AC: 1AN: 150722Hom.: 0 Cov.: 31
GnomAD3 exomes AF: 0.0000535 AC: 11AN: 205610Hom.: 0 AF XY: 0.0000636 AC XY: 7AN XY: 110110
GnomAD4 exome AF: 0.0000188 AC: 27AN: 1437548Hom.: 0 Cov.: 31 AF XY: 0.0000281 AC XY: 20AN XY: 712402
GnomAD4 genome AF: 0.00000663 AC: 1AN: 150722Hom.: 0 Cov.: 31 AF XY: 0.00 AC XY: 0AN XY: 73538
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Aug 19, 2024 | The c.268C>G (p.Q90E) alteration is located in exon 4 (coding exon 3) of the ACTR3C gene. This alteration results from a C to G substitution at nucleotide position 268, causing the glutamine (Q) at amino acid position 90 to be replaced by a glutamic acid (E). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at